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Accepted 17 August 2015Chronic dermatitis or pruritus affecting the female genital and perianal skin can be challenging to properly
diagnose and manage. The differential diagnosis generally includes allergic, inﬂammatory, infectious, and
neoplastic conditions. We report the case of a 52-year-old woman with a 6-month history of a progressive,
debilitating vulvar and perianal rash that highlights the multifaceted nature of female genital dermatoses.
© 2015 The Authors. Published by Elsevier Inc. on behalf of Women's Dermatologic Society. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 52-year-old woman presented to our ofﬁce for a second opinion
with a 6-month history of a painful and pruritic genital and perianal
rash. Initially, the rash presented on her superior gluteal cleft as a
painful, round, ulcerated erythematous plaque. She was evaluated at
an outside dermatology clinic and prescribed treatment with a mild
topical steroid; despite this treatment, her eruption expanded to
include her entire gluteal cleft, perineum, vulva, and inguinal folds.
Consultations with several dermatologists and infectious disease
specialists resulted in an extensive workup and numerous treatments
that were unsuccessful. She ﬁrst attempted stronger topical steroids with
liberal emollients. Skin cultures were positive for Group B Streptococcus,
for which she was treated with oral antibiotics, including cephalexin and
ciproﬂoxacin, in addition to topical ketoconazole and repeated courses of
oral ﬂuconazole for presumed Candida vaginitis. She developed
pelvic lymphadenopathy, thought to be secondary to her dermatitis on
MRI evaluation.
The patient was a professional with no signiﬁcant past medical
history. She took no chronic medications or supplements. She was in a
long-term monogamous relationship with a female partner, who was
unaffected by the rash. She was premenopausal with no history of
chronic skin or venereal disease.
Despite all attempts, her skin became progressively eroded and
weepy, with adherent crusts that made separating the skin painful
and routine hygiene difﬁcult. Her activities of daily living suffered due
to the pain, discharge, and odor; she eventually had to resort to a
position working from home. Ultimately, she was prescribed severalf interest to report.
er Inc. on behalf of Women's Dercourses of prednisone, which somewhat improved her symptoms.
After her last course of prednisone, she was devastated to note not
only recurrence of the rash, but also new involvement of her armpits
and ﬂexural surfaces of her arms.
When she presented to our clinic, physical examination revealed
tender, erythematous, edematous plaques with desquamative sheets of
scale, erosions, and ulcers of her vulva (Fig. 1a), perineal and perianal
skin (Fig. 1b), inguinal folds, and gluteal cleft. There was copious
mucopurulent drainage on her vulva. Scattered thin erythematous
plaques were noted in her axillary vaults and antecubital fossae.
Due to the complex presentation, the following tests were
performed: bacterial and fungal cultures, herpes simplex virus (HSV)
viral culture and direct ﬂuorescent antibody screen, punch biopsy of the
involved axillary and perianal skin, and comprehensive patch testing.
Bacterial culture revealed Group B Streptococcus and Klebsiella
pneumoniae. Fungal culture revealed Candida glabrata, resistant to
ﬂuconazole. Viral cultures and direct ﬂuourescent antibody screen
were positive for HSV.
Punch biopsies from the perineum and the axilla revealed
spongiotic dermatitis with a brisk superﬁcial perivascular inﬂamma-
tory inﬁltrate of lymphocytes and numerous eosinophils, suggestive
of allergic contact dermatitis (Fig. 2).
Patch testing revealed 3+ reaction to methyisothiazolinone (MI)
and 1+ reaction to methylisothiazolinone-methylchloroisothiazolinone
(MCI) mixture (Fig. 3). These allergens were relevant, as the patient had
used several brands of wet wipes and feminine cleansers containing the
offending allergens.
The patient was treated with trimethoprim-sulfamethoxazole,
voriconazole, and valacyclovir, with tremendous improvement in pain
and erythema within several days. Strict avoidance of products
containing the allergens induced near-resolution within 2 weeks.
Though she had a bout of hand dermatitis after using a soap
containing MI, her vulvar rash has otherwise remained controlled
without the use of topical medications at 18 months of follow-up.matologic Society. This is an open access article under the CC BY-NC-ND license
Fig. 1. (a) Erythema, edema, and sheets of desquamative scale of the vulva, inguinal
folds, perianal skin, and gluteal cleft. (b) Edematous, erythematous plaques of the
gluteal cleft with adherent crusts and desquamative sheets of scale.
Fig. 2. Punch biopsy specimen from the gluteal cleft and the axilla revealed similar
ﬁndings. Histologic sections revealed spongiotic dermatitis with a superﬁcial- and
mid-dermal perivascular inﬁltrate of lymphocytes and eosinophils consistent with
allergic contact dermatitis. (H&E, 40×).
Fig. 3. Patch test results, ﬁnal read at 96 hours. 3+ reaction to methylisothiazolinone;
1+ reaction to methylisothiazolinone:methylisochlorothiazolinone mixture.
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Dermatoses affecting the female genital tract can be challenging
to optimally diagnose and treat. This case illustrates that several
underlying pathologies may overlap to produce a complicated clinical
syndrome, and separate management of eachmay not induce complete
remission of the disease.
MI is a biocidal preservative used alone or in combination with
MCI in cosmetics, wet wipes, and household products, including
cleaning solutions and paint (Alwan et al., 2014). It has caused a
recent epidemic of contact allergy, resulting in MI being named the
American Contact Dermatitis Society’s 2013 Contact Allergen of the
year (Castanedo-Tardana and Zug, 2013). Contact sensitization to MI
is associated with occupational dermatitis in painters and beauticians
as well as anogenital or airborne allergic contact dermatitis (Uter
et al., 2013), among other patterns of clinical disease. Many topical
products used in female genital care, including washes, powders,
wipes, and douches, contain this product.
A compromised skin barrier creates a portal of entry for cutaneous
infections. Defensins are components of the innate immune system
with broad antibacterial, antiviral, and antifungal activity (Jarczak
et al., 2013). The cytokines that drive allergic contact dermatitis,
including interleukin-4, -10, and -13, downregulate human defensins.
The depletion of defensins may be linked to increased susceptibility to
polymicrobial infections (Howell et al., 2006). In our patient, the
compromised barrier allowed both Gram-positive and Gram-negative
bacterial infection,which could only be deﬁnitively treated after culture
and sensitivities were obtained.
Candida vulvovaginitis is increasing in frequency, as is ﬂuconazole
resistance among Candida isolates (Zhang et al., 2014). C. glabrata is a
more virulent yeast than Candida albicans, associated with systemic
illness (Pieralli et al., 2014), failed joint implants (Skedros et al.,
2014), and intrauterine fetal loss (Ozer et al., 2013). Prior exposure to
ﬂuconazole may be a risk factor for invasive fungal disease (Zilberberg
et al., 2014) and may portend a higher mortality once invasion has
occurred (Colombo et al., 2014). Rigorous use of diagnostic tests to
properly identify fungal organisms, coupled with the judicious use of
antifungal agents, may serve to stem the rising tide of invasive fungal
disease and antifungal resistance (Lestner et al., 2015), as antibiotic
stewardship may be reducing bacterial resistance to antibiotics
(JHuttner et al., 2014).
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infections, compromised skin barriers may increase susceptibility to
viral infections. Eczema herpeticum (Kaposi varicelliform eruption) is
a well-recognized phenomenon of viral superinfection of preexisting
dermatoses such as atopic dermatitis (Olson et al., 2008). However,
recent evidence suggests that the spectrum of clinical disease may be
much broader than the classic acute, life-threatening eruption (Frish
and Siegfried, 2011). With viral infections as much as with fungal
infections, the judicious use of diagnostic tests is of utmost importance
to avoid missing a chronic, indolent viral infection.
Additionally, the lack of history of genital or perianal herpes and
sexual orientation of our patient need not obviate testing for viral
infection. Initial infectionwithHSVmay ormay not induce disease; viral
shedding is common prior to and after secondary recurrences, with or
without an accompanying vesicular eruption (Chayavichitsilp et al.,
2009). Based on epidemiological data from the most recent National
Health and Nutrition Examination Study, women who have sex with
women have the highest prevalence of HSV-2 infection, greater than
men who have sex with men, men who do not have sex with men, and
women who do not have sex with women (Xu et al., 2010a, 2010b).
Optimal management of complex anogenital dermatoses requires
a step-wise approach. A careful history must be taken, with particular
focus on the duration of the problem, including ﬂuctuations in
intensity and any associated symptoms: blistering, itching, burning,
drainage, etc. Co-existing illnesses, such as diabetes; medications,
including antibiotics; and chronic skin diseases, like psoriasis or lichen
planus, can all play a role in the development or maintenance of an
anogenital problems.
Also important are the use of, and response to, prescribed and
nonprescribed medications during the course of the malady. Topical
steroids may exacerbate infections, while anesthetic products may
induce contact dermatitis; antibiotics may induce some positive
change, but result in an opportunistic yeast infection. Attention
should also be paid to personal hygienic practices, including the use
soaps or cleansing wipes, lotions, or sprays, as irritating or allergenic
substances are commonly found in this often-overlooked component
of the history.
A careful physical exam is critical to help deﬁne further testing and
treatment considerations. Bacterial infections commonly present with
erythema, edema, and tenderness of the involved skin; frank pus is a
less likely ﬁnding. Although Streptococcus classically affects the
perianal skin, vulvar involvement is common, as is polymicrobial
involvement in compromised skin. The so-called “satellite papules”
that herald Candida are papules of pustules at the periphery of a moist,
shiny erythematous plaque often with overlying soft, caseous crust.
Clues to the presence of herpes virus are grouped vesicles, erosions,
or crusts on an erythematous base. The judicious use of cultures
with susceptibility testing is crucial to avoid incomplete diagnosis or
treatment failure.
In addition to infections, primary inﬂammatory skin diseases
affecting the female anogenital region include psoriasis, lichen
planus, lichen sclerosus et atrophicus, allergic or irritant contact
dermatitis, and, rarely, atopic dermatitis. Clues to the presence of
allergic contact dermatitis include well-marginated or symmetric
erythematous scaly plaques.
Further testing should stem from the physical examination ﬁndings.
Swab cultures for bacterial and fungal organisms should routinely be
obtained. A low threshold for viral studies should be maintained,
particularly in patients with disruption of the epidermis with ulcers,
erosions, or blisters. Punch biopsy should also be performed if theclinical picture is not clear or if the patient does not respond to treatment
as expected.
Regardless of the clinical suspicion for contact dermatitis, fragrance-
free, dye-free, and otherwise “hypoallergenic” products should be used
ina patient’s personal care in addition to anyprescribed treatments. This
“anti-irritant” regimen should include laundry detergent, body wash or
soap, and emollients. Patch testing can be a useful and occasionally
necessary tool tohelpdeﬁne the root causeof allergic contact dermatitis.
Patch testing should be undertaken for patients with physical exam or
histologicﬁndings suspicious of allergic contact dermatitis. Additionally,
any patient with a chronic course of dermatitis with limited or poor
response to treatment should undergo patch testing.
Holistic care is required to optimally care for women with chronic
genital eruptions. We report the case of a patient with a progressive,
debilitating vulvovaginal and perianal eruption initiated by allergic
contact dermatitis and complicated by bacterial, viral, and fungal
infection.A step-wiseapproach to thediagnosisof anogenital dermatoses
is also presented. The answer to the important question of “infection or
allergy?” can be “both.”
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